Enzymotec (ENZY) Tops Q2 EPS by 5c, Updates FY Guidance

Enzymotec (NASDAQ: ENZY) reported Q2 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.39 million.

Enzymotec sees FY2015 EPS of $0.28-$0.36, versus the consensus of $0.28. Enzymotec sees FY2015 revenue of $53-59 million, versus the consensus of $53.38 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c